Bridgeway Capital Management’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $363K | Buy |
+106,000
| New | +$330K | 0.01% | 930 |
|
|
2026
Q1 | – | Sell |
-62,681
| Closed | -$176K | – | 1296 |
|
|
2025
Q4 | $176K | Sell |
62,681
-535,677
| -90% | -$1.91M | ﹤0.01% | 1044 |
|
|
2025
Q3 | $2.87M | Sell |
598,358
-750
| -0.1% | -$4.77K | 0.06% | 427 |
|
|
2025
Q2 | $5.45M | Sell |
599,108
-20,126
| -3% | -$148K | 0.13% | 217 |
|
|
2025
Q1 | $5.59M | Buy |
619,234
+10,613
| +2% | +$112K | 0.14% | 201 |
|
|
2024
Q4 | $7.95M | Sell |
608,621
-22,745
| -4% | -$303K | 0.18% | 171 |
|
|
2024
Q3 | $9.91M | Buy |
631,366
+17,152
| +3% | +$260K | 0.21% | 142 |
|
|
2024
Q2 | $8.29M | Buy |
614,214
+23,040
| +4% | +$472K | 0.19% | 158 |
|
|
2024
Q1 | $16.4M | Buy |
591,174
+62,509
| +12% | +$1.39M | 0.33% | 62 |
|
|
2023
Q4 | $10.2M | Buy |
528,665
+24,853
| +5% | +$450K | 0.22% | 133 |
|
|
2023
Q3 | $8.14M | Buy |
503,812
+20,540
| +4% | +$365K | 0.2% | 148 |
|
|
2023
Q2 | $9.2M | Sell |
483,272
-92,373
| -16% | -$1.65M | 0.22% | 130 |
|
|
2023
Q1 | $8.38M | Buy |
575,645
+112,045
| +24% | +$2.01M | 0.22% | 121 |
|
|
2022
Q4 | $9.05M | Buy |
463,600
+372,000
| +406% | +$7.26M | 0.23% | 98 |
|
|
2022
Q3 | $2.21M | Sell |
91,600
-57,100
| -38% | -$1.76M | 0.06% | 491 |
|
|
2022
Q2 | $4.68M | Sell |
148,700
-64,800
| -30% | -$2.35M | 0.11% | 333 |
|
|
2022
Q1 | $9.4M | Sell |
213,500
-131,000
| -38% | -$5.62M | 0.18% | 188 |
|
|
2021
Q4 | $15M | Sell |
344,500
-50,000
| -13% | -$1.96M | 0.28% | 92 |
|
|
2021
Q3 | $12.3M | Buy |
394,500
+9,900
| +3% | +$390K | 0.24% | 117 |
|
|
2021
Q2 | $16.3M | Buy |
384,600
+22,400
| +6% | +$871K | 0.29% | 90 |
|
|
2021
Q1 | $13.6M | Buy |
362,200
+24,900
| +7% | +$779K | 0.25% | 110 |
|
|
2020
Q4 | $9.12M | Sell |
337,300
-8,800
| -3% | -$226K | 0.19% | 145 |
|
|
2020
Q3 | $8.69M | Sell |
346,100
-4,900
| -1% | -$71.5K | 0.2% | 129 |
|
|
2020
Q2 | $2.67M | Buy |
351,000
+45,000
| +15% | +$329K | 0.05% | 336 |
|
|
2020
Q1 | $2.8M | Sell |
306,000
-100,000
| -25% | -$604K | 0.06% | 252 |
|
|
2019
Q4 | $2.1M | Buy |
406,000
+306,000
| +306% | +$1.97M | 0.03% | 524 |
|
|
2019
Q3 | $581K | Hold |
100,000
| – | – | 0.01% | 886 |
|
|
2019
Q2 | $320K | Buy |
+100,000
| New | +$341K | ﹤0.01% | 1083 |
|
|
2016
Q4 | – | Sell |
-74,200
| Closed | -$2.58M | – | 1449 |
|
|
2016
Q3 | $2.58M | Sell |
74,200
-650
| -0.9% | -$22.8K | 0.04% | 431 |
|
|
2016
Q2 | $2.8M | Buy |
74,850
+650
| +0.9% | +$24.4K | 0.04% | 386 |
|
|
2016
Q1 | $3M | Hold |
74,200
| – | – | 0.05% | 359 |
|
|
2015
Q4 | $2.67M | Hold |
74,200
| – | – | 0.05% | 390 |
|
|
2015
Q3 | $2.37M | Hold |
74,200
| – | – | 0.05% | 429 |
|
|
2015
Q2 | $2.52M | Hold |
74,200
| – | – | 0.05% | 431 |
|
|
2015
Q1 | $2.51M | Hold |
74,200
| – | – | 0.05% | 450 |
|
|
2014
Q4 | $2.6M | Buy |
+74,200
| New | +$2.5M | 0.06% | 423 |
|
Other funds holding ACH
CCM
ICM
PCMI
Bridgeway Capital Management's ACH Position: Q2 2026 in Review
Bridgeway Capital Management opened a new position in Accendra Health (ACH) in Q2 2026: 106,000 shares worth $363K. The stake represents 0.01% of the portfolio and ranks #930 among its holdings. This is a return to the name: Bridgeway Capital Management previously reported a position in ACH as recently as Q4 2025.
Bridgeway Capital Management first reported a position in ACH in Q4 2014 and has held it in 36 quarters since. The position peaked at $16.4M in Q1 2024. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- Bridgeway Capital Management held 106,000 shares of Accendra Health worth $363K as of Q2 2026.
- Accendra Health was a new Bridgeway Capital Management position in Q2 2026.
- Accendra Health made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #930 holding.
- Bridgeway Capital Management first reported a position in Accendra Health in Q4 2014 and has held it in 36 quarters since.
- Bridgeway Capital Management's Accendra Health position peaked at $16.4M in Q1 2024.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.